** Shares of Genetic Signatures GSS.AX down as much as 4.6% at its record low level of A$0.21
** The molecular diagnostics firm posts Q2 FY26, sales of A$3.3 million ($2.22 million), down from A$3.8 million a year ago
** About 422,306 shares change hands, 3.7x 30-day average
** Stock fell 60.3% in 2025
($1 = 1.4857 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))